查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423230

2024-2032 年按产品类型、应用、最终用户和地区分類的 DNA 定序产品市场报告

DNA Sequencing Products Market Report by Product Type, Application, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

2023年全球DNA定序产品市场规模达69亿美元。展望未来， IMARC Group预计到2032年市场规模将达到155亿美元，2024-2032年复合年增长率（CAGR）为9%。人们对血统测试和谱系学的兴趣日益浓厚，基于云和人工智慧驱动的生物资讯解决方案的出现，DNA测序越来越多地融入无创产前测试和癌症诊断，以及学术机构、医疗保健提供者和医疗机构之间的合作不断加强。生技公司是推动市场的一些因素。

DNA 定序产品是彻底改变遗传学和分子生物学领域的尖端技术。这些产品能够确定 DNA 分子中核苷酸的精确顺序，为了解生物体的基因组成提供宝贵的见解。 DNA 定序在各种科学和医学应用中发挥着至关重要的作用，包括基因研究、个人化医疗、法医学和遗传疾病研究。提供不同类型的 DNA 定序产品，从传统的桑格定序到现代高通量次世代定序 (NGS) 平台。桑格定序作为先驱方法，仍适用于某些应用，而 NGS 则提供快速、经济高效的高通量定序功能。这些产品不断发展，不断进步，从而提高了准确性、延长了读取长度并降低了成本。因此，它们已成为各领域不可或缺的工具，推动突破性的发现，为精准医学的进步和我们对生命遗传基础的理解做出贡献。

DNA 定序技术的快速进步对市场做出了重大贡献。特别是次世代定序 (NGS) 平台透过提供快速、高通量和经济高效的定序功能，使该领域发生了革命性变化，使研究人员、临床医生甚至消费者更容易获得 DNA 定序。此外，DNA 定序在不同领域的广泛应用也促进了市场的成长。在研究中，DNA 定序用于探索各种生物体的基因组，从而在遗传学、演化和疾病机制方面取得重大发现。 DNA 定序应用于医疗保健领域的个人化医疗、基因检测和罕见遗传疾病的诊断，从而促进了医学界对这些产品的需求。此外，遗传疾病的日益普及以及人们对基因检测对于预防保健重要性的认识不断提高，也推动了DNA定序产品的市场成长。法医分析和农业作物改良中的 DNA 定序扩大了其市场范围。此外，定序技术提供者和研究机构之间的合作和伙伴关係加速了产品的开发和采用。因此，定序准确性、读长和资料分析能力的不断提高催化了市场。此外，政府的措施、对基因组研究的资金支持以及 DNA 定序相关成本的降低，使这些产品更容易被更广泛的受众所使用，进一步刺激了市场扩张。

DNA 定序产品市场趋势/驱动因素：

慢性病和遗传性疾病盛行率不断上升

慢性病和遗传性疾病盛行率的不断上升已成为推动市场的重要因素。由于这些健康状况持续影响全球很大一部分人口，因此越来越需要准确和早期的诊断，以促进有效的治疗和管理。 DNA 定序对于识别与慢性疾病和失调相关的遗传变异和突变至关重要。透过分析个人的 DNA，医疗保健专业人员可以找出导致这些疾病发展的特定遗传因素，从而根据个人独特的基因组成製定个人化的治疗计划。此外，随着对疾病遗传基础的了解不断深入，DNA 定序对于高风险个体的早期筛检和预测测试变得至关重要。及早发现遗传倾向使个人及其医疗保健提供者能够采取积极措施来预防或减轻这些疾病的影响。随着研究人员、临床医生和消费者认识到遗传讯息在改变医疗保健和改善受慢性病和遗传性疾病影响的患者预后方面的潜力，对这些产品的需求可能会继续增长。

DNA 定序在药物研究和药物开发的应用不断增加

DNA 定序在药物研究和药物开发中的日益普及正在推动市场发展。 DNA 定序为疾病的遗传基础和潜在治疗标靶提供了宝贵的见解，彻底改变了药物发现过程。借助下一代定序（NGS）技术，研究人员可以进行大规模基因组研究，并有效识别与特定疾病或药物反应相关的遗传变异。 DNA 定序能够识别有助于患者分层的生物标记物，帮助製药公司设计和进行更有针对性的临床试验。此外，DNA 定序有助于罕见疾病的研究和先前难以捉摸的新药物标靶的发现。它使研究人员能够以前所未有的详细程度了解疾病的潜在分子机制，为精准医学的发展铺平道路。随着製药公司越来越认识到基因组学在药物开发中的价值，对 DNA 测序产品的需求预计将继续增长，在推进药物研究和将创新疗法推向市场方面发挥关键作用。

这些产品在农业的使用越来越多

DNA 定序产品在农业中的使用不断增加推动了市场的成长。 DNA 定序技术能够对农作物、牲畜和农业害虫进行精确、有效率的基因组分析，彻底改变了农业产业。在作物改良中，DNA 定序对于识别与抗病性、产量潜力和营养成分等所需性状相关的遗传标记至关重要。这些资讯可帮助育种者透过标记辅助选择开发新品种，加速育种过程并提高作物性能。 DNA 定序可帮助牲畜了解遗传多样性和育种计画的潜力，以增强牲畜物种的理想性状。反过来，这可以提高生产力并改善动物健康。此外，DNA 定序有助于研究农业害虫和病原体，有助于制定有针对性的害虫管理策略，减少有害化学物质的使用并促进永续农业。随着农业部门寻求创新和有效的方法来提高生产力和永续性，对 DNA 定序产品的需求预计将进一步增加，从而推动农业进步并为全球粮食安全做出贡献。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球 DNA 定序产品市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：依产品类型
  • 市场区隔：按应用
  • 市场区隔：按最终用户
  • 市场区隔：按技术
  • 市场区隔：按地区
  • 市场预测
  • SWOT分析
    • 概述
    • 优势
    • 弱点
    • 机会
    • 威胁
  • 价值链分析
    • 研究与开发
    • 原物料采购
    • 製造业
    • 分配
    • 最终用途
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁

第 6 章：市场区隔：依产品类型

  • 耗材和试剂
    • 市场走向
    • 市场预测
  • 装置
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 生物标誌物
    • 市场走向
    • 市场预测
  • 诊断
    • 市场走向
    • 市场预测
  • 生殖健康
    • 市场走向
    • 市场预测
  • 法证学
    • 市场走向
    • 市场预测
  • 个人化医疗
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 学术和政府研究机构
    • 市场走向
    • 市场预测
  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 医院和诊所
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 市场走向
    • 市场预测
  • 欧洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测

第 10 章：竞争格局

  • 市场结构
  • 市场区隔：按关键参与者
  • 关键参与者简介
    • Illumina Inc
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Pacific Biosciences of California, Inc.
    • Beckman Coulter
Product Code: SR112024A839

Abstract

The global DNA sequencing products market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9% during 2024-2032. The increasing interest in ancestry testing and genealogy, the emergence of cloud-based and AI-driven bioinformatics solutions, the rising integration of DNA sequencing into non-invasive prenatal testing and cancer diagnostics, and the growing collaborations between academic institutions, healthcare providers, and biotechnology companies are some of the factors propelling the market.

DNA sequencing products are cutting-edge technologies that have revolutionized the field of genetics and molecular biology. These products enable the determination of the precise order of nucleotides in a DNA molecule, providing invaluable insights into the genetic makeup of organisms. DNA sequencing plays a crucial role in various scientific and medical applications, including gene research, personalized medicine, forensics, and the study of genetic diseases. Different types of DNA sequencing products are available, ranging from traditional Sanger sequencing to modern high-throughput Next-Generation Sequencing (NGS) platforms. Sanger sequencing, the pioneer method, remains relevant for certain applications, while NGS offers rapid, cost-effective, and high-throughput sequencing capabilities. These products are continually evolving, with advancements leading to improved accuracy, longer read lengths, and reduced costs. As a result, they have become indispensable tools in diverse fields, driving groundbreaking discoveries and contributing to advancements in precision medicine and our understanding of the genetic basis of life.

The rapid advancements in DNA sequencing technology are significantly contributing to the market. Next-Generation Sequencing (NGS) platforms, in particular, have revolutionized the field by providing rapid, high-throughput, and cost-effective sequencing capabilities, making DNA sequencing more accessible to researchers, clinicians, and even consumers. Furthermore, the expanding applications of DNA sequencing across diverse fields have contributed to market growth. In research, DNA sequencing is used to explore the genomes of various organisms, leading to significant discoveries in genetics, evolution, and disease mechanisms. DNA sequencing is employed in healthcare for personalized medicine, genetic testing, and diagnosis of rare genetic disorders, fostering demand for these products in the medical community. Moreover, the increasing prevalence of genetic diseases and the rising awareness of the importance of genetic testing for preventive healthcare have also fueled the market growth of DNA sequencing products. DNA sequencing in forensic analysis and agriculture for crop improvement has extended its market reach. Besides, collaborations and partnerships between sequencing technology providers and research institutions have accelerated product development and adoption. As a result, the continuous improvement in sequencing accuracy, read lengths, and data analysis capabilities have catalyzed the market. Additionally, the government's initiatives, funding support for genomic research, and decreasing costs associated with DNA sequencing have made these products more accessible to a broader audience, further stimulating market expansion.

DNA sequencing products Market Trends/Drivers:

Increasing prevalence of chronic diseases and genetic disorders

The increasing prevalence of chronic diseases and genetic disorders has become a significant factor catalyzing the market. As these health conditions continue to affect a large portion of the global population, there is a growing need for accurate and early diagnosis to facilitate effective treatment and management. DNA sequencing is crucial in identifying genetic variations and mutations associated with chronic diseases and disorders. By analyzing an individual's DNA, healthcare professionals can pinpoint specific genetic factors contributing to the development of these conditions, enabling personalized treatment plans based on a person's unique genetic makeup. Moreover, as the understanding of the genetic basis of diseases advances, DNA sequencing becomes essential in early screening and predictive testing for individuals at risk. Early detection of genetic predispositions empowers individuals and their healthcare providers to take proactive measures to prevent or mitigate the impact of these diseases. The demand for these products is likely to continue growing as researchers, clinicians, and consumers recognize the potential of genetic information in transforming healthcare and improving patient outcomes for those affected by chronic diseases and genetic disorders.

Rising adoption of DNA sequencing in pharmaceutical research and drug development

The rising adoption of DNA sequencing in pharmaceutical research and drug development is propelling the market. DNA sequencing has revolutionized the drug discovery process by providing invaluable insights into the genetic basis of diseases and potential therapeutic targets. With Next-Generation Sequencing (NGS) technologies, researchers can perform large-scale genomic studies and efficiently identify genetic variations associated with specific diseases or drug responses. DNA sequencing enables the identification of biomarkers that can aid in patient stratification, helping pharmaceutical companies design and conduct more targeted clinical trials. Additionally, DNA sequencing facilitates the study of rare diseases and the discovery of novel drug targets that were previously elusive. It allows researchers to understand the underlying molecular mechanisms of diseases at a level of detail never before possible, paving the way for the development of precision medicines. As pharmaceutical companies increasingly recognize the value of genomics in drug development, the demand for DNA sequencing products is expected to continue progressing, playing a pivotal role in advancing pharmaceutical research and bringing innovative therapies to the market.

Growing use of these products in agriculture

The growing use of DNA sequencing products in agriculture has driven the market growth. DNA sequencing technologies have revolutionized the agricultural industry by enabling precise and efficient genomic analysis of crops, livestock, and agricultural pests. In crop improvement, DNA sequencing is crucial in identifying genetic markers associated with desirable traits such as disease resistance, yield potential, and nutritional content. This information aids breeders in developing new varieties through marker-assisted selection, accelerating the breeding process and improving crop performance. DNA sequencing helps livestock understand the genetic diversity and potential for breeding programs to enhance desirable traits in livestock species. This, in turn, can lead to increased productivity and improved animal health. Furthermore, DNA sequencing is instrumental in studying agricultural pests and pathogens, enabling the development of targeted pest management strategies that reduce the use of harmful chemicals and promote sustainable agriculture. As the agricultural sector seeks innovative and efficient ways to enhance productivity and sustainability, the demand for DNA sequencing products is expected to increase further, driving advancements in agriculture and contributing to global food security.

DNA Sequencing Products Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global DNA sequencing products market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type, application and end-user.

Breakup by Product Type:

Consumables and Reagents

Equipments

Consumables and reagents dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes consumables and reagents, and equipment. According to the report, consumables and reagents represented the largest segment.

The consumables and reagents encompass various essential components and materials for conducting DNA sequencing experiments and analysis. Consumables include items like DNA extraction kits, sequencing libraries, and flow cells, while reagents consist of chemical substances and enzymes required during the sequencing process. The significance of this market segment lies in its vital role in facilitating DNA sequencing procedures, making it a crucial investment for researchers, clinicians, and other users.

As DNA sequencing technologies evolve and advance, the demand for high-quality and specialized consumables and reagents augments, thereby contributing to the segment's substantial growth. Moreover, the consumables and reagents segment often enjoys a higher return on investment for manufacturers, as researchers and laboratories require regular restocking of these items to sustain their sequencing operations. As the DNA sequencing market expands, this segment is expected to maintain its dominance and contribute significantly to the overall revenue of the industry.

Breakup by Application:

Biomarkers

Diagnostics

Reproductive Health

Forensics

Personalized Medicine

Others

Biomarkers dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes biomarkers, diagnostics, reproductive health, forensics, personalized medicine, and others. According to the report, biomarkers represented the largest segment.

Biomarkers are specific genetic, biochemical, or molecular characteristics that provide valuable insights into an individual's health status and treatment response. In the realm of DNA sequencing, biomarkers hold immense importance, especially in personalized medicine. Biomarkers derived from DNA sequencing data aid in predicting treatment outcomes, enabling healthcare professionals to tailor therapies based on a patient's genetic profile. This personalized approach enhances treatment efficacy and minimizes adverse effects, optimizing patient outcomes.

The popularity of biomarkers in DNA sequencing products is driven by the increasing understanding of the link between genetics and disease, making them valuable tools in diagnostics, prognostics, and therapeutic decision-making. As the field of genomics continues to advance and more biomarkers are identified, the demand for DNA sequencing products, particularly those focused on biomarker analysis, is expected to grow significantly, further solidifying its prominent position in the market segment.

Breakup by End-User:

Academic and Government Research Institutes

Pharmaceutical and Biotechnology Companies

Hospitals and Clinics

Others

Academic and government research institutes dominate the market

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes academic and government research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others. According to the report, academic and government research institutes represented the largest segment.

DNA sequencing products are currently experiencing significant utilization in academic and government research institutes. This trend can be attributed to the abundant research and development projects in these institutions that involve practical data analysis implementations and next-generation sequencing (NGS). Academic and government research institutes are at the forefront of scientific exploration. DNA sequencing plays a crucial role in various areas of study, including genomics, molecular biology, agriculture, and healthcare research.

The accessibility of advanced DNA sequencing technologies and the expertise of researchers in these institutions contribute to the widespread adoption of these products. Furthermore, these research institutes often collaborate with DNA sequencing companies, fostering partnerships that promote innovation and enhance product development. As a result, the demand for these products remains robust in the academic and government sectors, driving market growth and facilitating groundbreaking discoveries and advancements in scientific knowledge and applications.

Breakup by Region:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

North America exhibits a clear dominance, accounting for the DNA sequencing products largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market.

The North American region is dominant in the global market. This can be attributed to several key factors driving the market growth in the region. The region has a substantial geriatric population, leading to an increased demand for genetic testing and personalized medicine to address age-related health concerns. Furthermore, the prevalence of various chronic diseases in North America has bolstered the adoption of DNA sequencing products for diagnostics, prognosis, and treatment decision-making. DNA sequencing is vital in identifying genetic factors contributing to these diseases, enabling targeted therapies and precision medicine approaches. Moreover, the region has several prominent drug manufacturers and biotechnology companies actively involved in genomic research and drug development. The presence of such industry players drives the demand for these products to support their research and clinical trials.

Competitive Landscape:

Top companies are bolstering market growth through several strategic approaches. They invest heavily in research and development to continuously improve their sequencing technologies, enhancing accuracy and scalability and reducing costs. This ensures that their products remain at the forefront of innovation and appeal to a broader customer base. Furthermore, these companies actively collaborate with academic institutions, research organizations, and healthcare providers to expand their customer reach and foster partnerships that drive product development and application. Additionally, they focus on expanding their product portfolios to cater to various customer needs, offering a range of DNA sequencing solutions tailored for different applications and industries. Moreover, effective marketing strategies, including targeted advertising, educational campaigns, and endorsements from key opinion leaders, create awareness and drive demand for their products. By employing these strategies and staying at the forefront of technological advancements, the top companies propel market growth and play a pivotal role in advancing genomics research, healthcare, agriculture, and other fields.

The report has provided a comprehensive analysis of the competitive landscape in the DNA sequencing products market. Detailed profiles of all major companies have also been provided.

Illumina Inc.

Thermo Fisher Scientific Inc.

F. Hoffmann-La Roche Ltd.

Pacific Biosciences of California, Inc.

Beckman Coulter

Recent Developments:

In 2019, Illumina announced a collaboration with Bristol-Myers Squibb to develop companion diagnostics for oncology treatments. The companies aimed to leverage Illumina's sequencing technology to identify genomic biomarkers that could help predict patient responses to specific cancer therapies.

In 2019, Thermo Fisher Scientific partnered with West China Hospital of Sichuan University to establish a Joint Precision Medicine Research Laboratory in China. The collaboration aimed to advance precision medicine research by integrating Thermo Fisher's genetic sequencing solutions with the hospital's clinical expertise.

In 2018, Roche announced a collaboration with Foundation Medicine, Inc. to develop and distribute FoundationOne CDx, a comprehensive genomic profiling assay. The collaboration aimed to expand access to comprehensive genomic testing for cancer patients and guide personalized treatment decisions.

Key Questions Answered in This Report

  • 1. What was the size of the global DNA sequencing products market in 2023?
  • 2. What is the expected growth rate of the global DNA sequencing products market during 2024-2032?
  • 3. What are the key factors driving the global DNA sequencing products market?
  • 4. What has been the impact of COVID-19 on the global DNA sequencing products market?
  • 5. What is the breakup of the global DNA sequencing products market based on the product type?
  • 6. What is the breakup of the global DNA sequencing products market based on the application?
  • 7. What is the breakup of the global DNA sequencing products market based on the end-user?
  • 8. What are the key regions in the global DNA sequencing products market?
  • 9. Who are the key players/companies in the global DNA sequencing products market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global DNA Sequencing Products Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Application
  • 5.6 Market Breakup by End-User
  • 5.7 Market Breakup by Technology
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
    • 5.11.1 Research and Development
    • 5.11.2 Raw Material Procurement
    • 5.11.3 Manufacturing
    • 5.11.4 Distribution
    • 5.11.5 End-Use
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product Type

  • 6.1 Consumables and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Biomarkers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Reproductive Health
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Forensics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Personalized Medicine
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Academic and Government Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hospitals and Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Market Breakup by Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Illumina Inc
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Description
      • 10.3.1.3 Product Portfolio
      • 10.3.1.4 Financials
      • 10.3.1.5 SWOT Analysis
    • 10.3.2 Thermo Fisher Scientific Inc.
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Description
      • 10.3.2.3 Product Portfolio
      • 10.3.2.4 Financials
      • 10.3.2.5 SWOT Analysis
    • 10.3.3 F. Hoffmann-La Roche Ltd.
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Description
      • 10.3.3.3 Product Portfolio
      • 10.3.3.4 Financials
      • 10.3.3.5 SWOT Analysis
    • 10.3.4 Pacific Biosciences of California, Inc.
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Description
      • 10.3.4.3 Product Portfolio
      • 10.3.4.4 Financials
      • 10.3.4.5 SWOT Analysis
    • 10.3.5 Beckman Coulter
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Description
      • 10.3.5.3 Product Portfolio
      • 10.3.5.4 Financials
      • 10.3.5.5 SWOT Analysis

List of Figures

  • Figure 1: Global: DNA Sequencing Products Market: Major Drivers and Challenges
  • Figure 2: Global: DNA Sequencing Products Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: DNA Sequencing Products Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: DNA Sequencing Products Market: Breakup by Application (in %), 2023
  • Figure 5: Global: DNA Sequencing Products Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: DNA Sequencing Products Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: DNA Sequencing Products Market: Breakup by Region (in %), 2023
  • Figure 8: Global: DNA Sequencing Products Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: DNA Sequencing Products Industry: SWOT Analysis
  • Figure 10: Global: DNA Sequencing Products Industry: Value Chain Analysis
  • Figure 11: Global: DNA Sequencing Products Industry: Porter's Five Forces Analysis
  • Figure 12: Global: DNA Sequencing Products Market: Consumables and Reagents (in Million US$), 2018 & 2023
  • Figure 13: Global: DNA Sequencing Products Market Forecast: Consumables and Reagents (in Million US$), 2024-2032
  • Figure 14: Global: DNA Sequencing Products Market: Equipments (in Million US$), 2018 & 2023
  • Figure 15: Global: DNA Sequencing Products Market Forecast: Equipments (in Million US$), 2024-2032
  • Figure 16: Global: DNA Sequencing Products Market (Applications in Biomarkers): Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: DNA Sequencing Products Market Forecast (Applications in Biomarkers): Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: DNA Sequencing Products Market (Applications in Diagnostics): Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: DNA Sequencing Products Market Forecast (Applications in Diagnostics): Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: DNA Sequencing Products Market (Application in Reproductive Health): Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: DNA Sequencing Products Market Forecast (Applications in Reproductive Health): Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: DNA Sequencing Products Market (Applications in Forensics): Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: DNA Sequencing Products Market Forecast (Applications in Forensics): Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: DNA Sequencing Products Market (Applications in Personalized Medicine): Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: DNA Sequencing Products Market Forecast (Applications in Personalized Medicine): Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: DNA Sequencing Products Market (Other Applications): Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: DNA Sequencing Products Market Forecast (Other Applications): Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: DNA Sequencing Products Market (in Academic and Government Research Institutes): Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: DNA Sequencing Products Market Forecast (in Academic and Government Research Institutes): Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: DNA Sequencing Products Market (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: DNA Sequencing Products Market Forecast (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: DNA Sequencing Products Market (in Hospitals and Clinics): Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: DNA Sequencing Products Market Forecast (in Hospitals and Clinics): Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: DNA Sequencing Products Market (Other End-Users): Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: DNA Sequencing Products Market Forecast (Other End-Users): Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Europe: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Europe: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia Pacific: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia Pacific: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Latin America: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Latin America: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Middle East and Africa: DNA Sequencing Products Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Middle East and Africa: DNA Sequencing Products Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: DNA Sequencing Products Market: Breakup by Key Players (in %), 2023

List of Tables

  • Table 1: Global: DNA Sequencing Products Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: DNA Sequencing Products Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: DNA Sequencing Products Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: DNA Sequencing Products Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: DNA Sequencing Products Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: DNA Sequencing Products Market: Competitive Structure
  • Table 7: Global: DNA Sequencing Products Market: Key Players